CardioCel - Bioscaffold

CardioCel Bioscaffold

• Require fewer interventions(1)
• Have the largest published data over the longest timeframe(1)
• Are the first and only to offer 3D bioscaffold 
• Improve hospital efficiencies overall(1)

Offered in three versions to address your specific surgical needs:

• CardioCel - for heart repair and reconstruction 
• CardioCel Neo - for more intricate procedures
• CardioCel 3D - shaped for great vessel repair

Unique Intraoperative Benefits and Procedural Efficacies

• Ready to use off the shelf; No thawing, rinsing or preparation required
• Elasticity virtually identical to human aortic valve leaflet(4)
• Stronger than the human aorta(4)
• The only bioscaffold with unparalleled calcium resistance(3)

Optimized clinical performance

• No antigenic or immunogenic stimulus(3,4,5)
• No calcium binding sites(3,4)
• No glutaraldehyde toxicity(4)
• Terminally sterilized for reduced risk of infection- SAL 10-6 (2)
• Proven native cell integration(3,4,5)

Enhanced procedural efficiency

• Easy to suture, trim
• Enhanced pliability
• Readily conforms to repair site
• Excellent hemostasis - resists suture line bleeding(9)

CardioCel Neo Bioscaffold

• CardioCel Neo has all the benefits of CardioCel but is refined to 0.3 mm thickness for the most intricate procedures. 

Surgical Applications

• Pericardial closure
• Repair of cardiac and vascular defects including intracardiac defects
• Septal defects, valve and annulus repair
• Great vessel reconstruction, peripheral vascular reconstruction and suture line buttressing

All the Benefits of CardioCel Optimally Shaped for Great Vessel Repair

Shape Matters: CardioCel 3D 60°

• Curved bioscaffold enables Roman Arch shaped reconstruction
• Roman Arch shape optimizes hemodynamics(6,7,8)
• Anisotropy which matches that of native aortic tissue in both circumferential and longitudinal tissue planes(10)

Growing evidence shows that shape matters in complex repair(1-8)

Gothic arch morphology derangements and mismatched dimensions are associated with poorer outcomes, including:

• Indexed End-Diastolic Volume
• Hypertension
• Intimal hyperplasia
• Cavopulmonary pressure

Surgical Applications

• Hypoplastic aortic arch (HAA)
• Interrupted aortic arch (IAA)
• Pulmonary artery (PA)
• Right ventricular outflow tract (RVOT) - Hood and TAP
• Baffle